Clinical Trials Logo

Clinical Trial Summary

Many athletes use beta2-agonists as treatment of airway hyperresponsiveness during exercise. High dose beta2-agonists may have an ergogenic effect on exercise performance. We hypotheis that the beta2-agonist, salbutamol, taken in high doses can improve muscle power and recovery during exercise in well-trained athletes.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)


Related Conditions & MeSH terms

  • Ergogenic Effects of Salbutamol in Healthy Males

NCT number NCT01415596
Study type Interventional
Source Bispebjerg Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date August 2011
Completion date August 2013